![Andrew Wilks](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Wilks
Oprichter bij SYN thesis med chem Pty Ltd.
Profiel
Andrew Wilks is the founder of SYN thesis med chem Pty Ltd.
He is currently a Director at Medicines Development for Global Health Ltd and a Non-Executive Director at Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
Actieve functies van Andrew Wilks
Bedrijven | Functie | Begin |
---|---|---|
Medicines Development for Global Health Ltd
![]() Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Directeur/Bestuurslid | - |
SYN thesis med chem Pty Ltd.
![]() SYN thesis med chem Pty Ltd. BiotechnologyHealth Technology SYN thesis med chem Pty Ltd. engages in the development and provision of molecule drug discovery services. It offers integrated drug discovery, medicinal and synthetic chemistry, single compound synthesis, and catalogue products. The company was founded by Andrew Wilks and Xian Bu and is headquartered in Parkville, Australia. | Oprichter | - |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
![]() Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
SYN thesis med chem Pty Ltd.
![]() SYN thesis med chem Pty Ltd. BiotechnologyHealth Technology SYN thesis med chem Pty Ltd. engages in the development and provision of molecule drug discovery services. It offers integrated drug discovery, medicinal and synthetic chemistry, single compound synthesis, and catalogue products. The company was founded by Andrew Wilks and Xian Bu and is headquartered in Parkville, Australia. | Health Technology |
Medicines Development for Global Health Ltd
![]() Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Health Technology |
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.
![]() Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer. | Commercial Services |